|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wotton D, Lo RS, Lee S and Massagué J: A
Smad transcriptional corepressor. Cell. 97:29–39. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bartholin L, Powers SE, Melhuish TA, Lasse
S, Weinstein M and Wotton D: TGIF inhibits retinoid signaling. Mol
Cell Biol. 26:990–1001. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hamid R and Brandt SJ: Transforming
growth-interacting factor (TGIF) regulates proliferation and
differentiation of human myeloid leukemia cells. Mol Oncol.
3:451–463. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Willer A, Jakobsen JS, Ohlsson E, Rapin N,
Waage J, Billing M, Bullinger L, Karlsson S and Porse BT: TGIF1 is
a negative regulator of MLL-rearranged acute myeloid leukemia.
Leukemia. 29:1018–1031. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nakakuki K, Imoto I, Pimkhaokham A, Fukuda
Y, Shimada Y, Imamura M, Amagasa T and Inazawa J: Novel targets for
the 18p11.3 amplification frequently observed in esophageal
squamous cell carcinomas. Carcinogenesis. 23:19–24. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hu ZL, Wen JF, Xiao DS, Zhen H and Fu CY:
Effects of transforming growth interacting factor on biological
behaviors of gastric carcinoma cells. World J Gastroenterol.
11:84–88. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu ZM, Tseng HY, Tsai HW, Su FC and Huang
HS: Transforming growth factor β-interacting factor-induced
malignant progression of hepatocellular carcinoma cells depends on
superoxide production from Nox4. Free Radic Biol Med. 84:54–64.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Wang H, Gao H, Xu B, Zhai W, Li J
and Zhang C: Elevated expression of TGIF is involved in lung
carcinogenesis. Tumour Biol. 36:9223–9231. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiang G, Yi Y, Weiwei H and Weiming W:
TGIF1 promoted the growth and migration of cancer cells in nonsmall
cell lung cancer. Tumour Biol. 36:9303–9310. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yeh BW, Wu WJ, Li WM, Li CC, Huang CN,
Kang WY, Liu ZM and Huang HS: Overexpression of TG-interacting
factor is associated with worse prognosis in upper urinary tract
urothelial carcinoma. Am J Pathol. 181:1044–1055. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang HS, Liu ZM, Chen PC, Tseng HY and
Yeh BW: TG-interacting factor-induced superoxide production from
NADPH oxidase contributes to the migration/invasion of urothelial
carcinoma. Free Radic Biol Med. 53:769–778. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang MZ, Ferrigno O, Wang Z, Ohnishi M,
Prunier C, Levy L, Razzaque M, Horne WC, Romero D, Tzivion G, et
al: TGIF governs a feed-forward network that empowers Wnt signaling
to drive mammary tumorigenesis. Cancer Cell. 27:547–560. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kwon YJ, Leibovitch BA, Bansal N, Pereira
L, Chung CY, Ariztia EV, Zelent A, Farias EF and Waxman S: Targeted
interference of SIN3A-TGIF1 function by SID decoy treatment
inhibits Wnt signaling and invasion in triple negative breast
cancer cells. Oncotarget. 8:88421–88436. 2017.PubMed/NCBI
|
|
15
|
Wang Y, Pan T, Wang H, Li L, Li J, Zhang C
and Yang H: Silencing of TGIF attenuates the tumorigenicity of A549
cells in vitro and in vivo. Tumour Biol. 37:12725–12730. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Zhai W, Wang H, Xia X and Zhang C:
Benzo(a)pyrene promotes A549 cell migration and invasion through
up-regulating Twist. Arch Toxicol. 89:451–458. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Z, Liu X, Feng B, Liu N, Wu Q, Han
Y, Nie Y, Wu K, Shi Y and Fan D: STIM1, a direct target of
microRNA-185, promotes tumor metastasis and is associated with poor
prognosis in colorectal cancer. Oncogene. 34:4808–4820. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Glondu M, Liaudet-Coopman E, Derocq D,
Platet N, Rochefort H and Garcia M: Down-regulation of cathepsin-D
expression by antisense gene transfer inhibits tumor growth and
experimental lung metastasis of human breast cancer cells.
Oncogene. 21:5127–5134. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hui L, Zhang S, Dong X, Tian D, Cui Z and
Qiu X: Prognostic significance of twist and N-cadherin expression
in NSCLC. PLoS One. 8:e621712013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu X, Yan C, Huang Y, Shi D, Fu Z, Qiu J
and Yin Y: Mouse double minute 2 (MDM2) upregulates Snail
expression and induces epithelial-to-mesenchymal transition in
breast cancer cells in vitro and in vivo. Oncotarget.
7:37177–37191. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Castillo LF, Tascón R, Lago Huvelle MR,
Novack G, Llorens MC, Dos Santos AF, Shortrede J, Cabanillas AM,
Bal de Kier Joffé E, Labriola L, et al: Glypican-3 induces a
mesenchymal to epithelial transition in human breast cancer cells.
Oncotarget. 7:60133–60154. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
De P, Carlson JH, Wu H, Marcus A,
Leyland-Jones B and Dey N: Wnt-beta-catenin pathway signals
metastasis-associated tumor cell phenotypes in triple negative
breast cancers. Oncotarget. 7:43124–43149. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Byun HJ, Darvin P, Kang DY, Sp N, Joung
YH, Park JH, Kim SJ and Yang YM: Silibinin downregulates MMP2
expression via Jak2/STAT3 pathway and inhibits the migration and
invasive potential in MDA-MB-231 cells. Oncol Rep. 37:3270–3278.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu X, Yan Q, Wang Y and Dong X: NTN4 is
associated with breast cancer metastasis via regulation of
EMT-related biomarkers. Oncol Rep. 37:449–457. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Min KW, Kim DH, Do SI, Kim K, Lee HJ, Chae
SW, Sohn JH, Pyo JS, Oh YH, Kim WS, et al: Expression patterns of
stromal MMP-2 and tumoural MMP-2 and −9 are significant prognostic
factors in invasive ductal carcinoma of the breast. APMIS.
122:1196–1206. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim D and Rhee S: Matrix
metalloproteinase-2 regulates MDA-MB-231 breast cancer cell
invasion induced by active mammalian diaphanous-related formin 1.
Mol Med Rep. 14:277–282. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sullu Y, Demirag GG, Yildirim A, Karagoz F
and Kandemir B: Matrix metalloproteinase-2 (MMP-2) and MMP-9
expression in invasive ductal carcinoma of the breast. Pathol Res
Pract. 207:747–753. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zheng L, Zhang YM, Zhan YZ and Liu CX:
Momordica cochinchinensis seed extracts suppress migration and
invasion of human breast cancer ZR-75-30 cells via down-regulating
MMP-2 and MMP-9. Asian Pac J Cancer Prev. 15:1105–1110. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen Y, Wang X, Chen G, Dong C and Zhang
D: The impact of matrix metalloproteinase 2 on prognosis and
clinicopathology of breast cancer patients: A systematic
meta-analysis. PLoS One. 10:e01214042015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pei S, Yang X, Wang H, Zhang H, Zhou B,
Zhang D and Lin D: Plantamajoside, a potential anti-tumor herbal
medicine inhibits breast cancer growth and pulmonary metastasis by
decreasing the activity of matrix metalloproteinase-9 and −2. BMC
Cancer. 15:9652015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ni X, Xia T, Zhao Y, Zhou W, Wu N, Liu X,
Ding Q, Zha X, Sha J and Wang S: Downregulation of miR-106b induced
breast cancer cell invasion and motility in association with
overexpression of matrix metalloproteinase 2. Cancer Sci.
105:18–25. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang YF, Yu Y, Song WZ, Zhang RM, Jin S,
Bai JW, Kang HB, Wang X and Cao XC: miR-410-3p suppresses breast
cancer progression by targeting Snail. Oncol Rep. 36:480–486. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma SY, Park JH, Jung H, Ha SM, Kim Y, Park
DH, Lee DH, Lee S, Chu IH, Jung SY, et al: Snail maintains
metastatic potential, cancer stem-like properties, and
chemoresistance in mesenchymal mouse breast cancer TUBO-P2J cells.
Oncol Rep. 38:1867–1876. 2017.PubMed/NCBI
|
|
34
|
Moody SE, Perez D, Pan TC, Sarkisian CJ,
Portocarrero CP, Sterner CJ, Notorfrancesco KL, Cardiff RD and
Chodosh LA: The transcriptional repressor Snail promotes mammary
tumor recurrence. Cancer Cell. 8:197–209. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Geradts J, de Herreros AG, Su Z, Burchette
J, Broadwater G and Bachelder RE: Nuclear Snail1 and nuclear ZEB1
protein expression in invasive and intraductal human breast
carcinomas. Hum Pathol. 42:1125–1131. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tran DD, Corsa CA, Biswas H, Aft RL and
Longmore GD: Temporal and spatial cooperation of Snail1 and Twist1
during epithelial-mesenchymal transition predicts for human breast
cancer recurrence. Mol Cancer Res. 9:1644–1657. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang K, Corsa CA, Ponik SM, Prior JL,
Piwnica-Worms D, Eliceiri KW, Keely PJ and Longmore GD: The
collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to
facilitate breast cancer metastasis. Nat Cell Biol. 15:677–687.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tran HD, Luitel K, Kim M, Zhang K,
Longmore GD and Tran DD: Transient SNAIL1 expression is necessary
for metastatic competence in breast cancer. Cancer Res.
74:6330–6340. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dey N, Barwick BG, Moreno CS,
Ordanic-Kodani M, Chen Z, Oprea-Ilies G, Tang W, Catzavelos C,
Kerstann KF, Sledge GW Jr, et al: Wnt signaling in triple negative
breast cancer is associated with metastasis. BMC Cancer.
13:5372013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tan Z, Zheng H, Liu X, Zhang W, Zhu J, Wu
G, Cao L, Song J, Wu S, Song L, et al: MicroRNA-1229 overexpression
promotes cell proliferation and tumorigenicity and activates
Wnt/β-catenin signaling in breast cancer. Oncotarget.
7:24076–24087. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yin L, Gao Y, Zhang X, Wang J, Ding D,
Zhang Y, Zhang J and Chen H: Niclosamide sensitizes triple-negative
breast cancer cells to ionizing radiation in association with the
inhibition of Wnt/β-catenin signaling. Oncotarget. 7:42126–42138.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li S, Li S, Sun Y and Li L: The expression
of β-catenin in different subtypes of breast cancer and its
clinical significance. Tumour Biol. 35:7693–7698. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lin SY, Xia W, Wang JC, Kwong KY, Spohn B,
Wen Y, Pestell RG and Hung MC: Beta-catenin, a novel prognostic
marker for breast cancer: Its roles in cyclin D1 expression and
cancer progression. Proc Natl Acad Sci USA. 97:pp. 4262–4266. 2000;
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Khramtsov AI, Khramtsova GF, Tretiakova M,
Huo D, Olopade OI and Goss KH: Wnt/beta-catenin pathway activation
is enriched in basal-like breast cancers and predicts poor outcome.
Am J Pathol. 176:2911–2920. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xu J, Prosperi JR, Choudhury N, Olopade OI
and Goss KH: β-catenin is required for the tumorigenic behavior of
triple-negative breast cancer cells. PLoS One. 10:e01170972015.
View Article : Google Scholar : PubMed/NCBI
|
